181
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Retrospective Study on the Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes in Northern Taiwan

, , & ORCID Icon
Pages 2539-2547 | Received 26 May 2023, Accepted 22 Aug 2023, Published online: 24 Aug 2023

References

  • Zhu N, Zhang D, Wang W, et al. China novel coronavirus investigating and research team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi:10.1056/NEJMoa2001017
  • Fauci AS, Lane HC, Redfield RR. Covid-19 - navigating the uncharted. N Engl J Med. 2020;382:1268–1269. doi:10.1056/NEJMe2002387
  • Han E, Chiou ST, McKee M, Legido-Quigley H. The resilience of Taiwan’s health system to address the COVID-19 pandemic. EClinicalMedicine. 2020;24:100437. doi:10.1016/j.eclinm.2020.100437
  • Wang CJ, Ng CY, Brook RH. Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing. JAMA. 2020;323:1341–1342. doi:10.1001/jama.2020.3151
  • Lee WC, Su SY. Epidemic trend of COVID-19 in Taiwan, May to June 2021. J Formos Med Assoc. 2022;121:580–581. doi:10.1016/j.jfma.2021.08.022
  • Carpenter R, DiChiacchio T, Barker K. Interventions for self-management of type 2 diabetes: an integrative review. Int J Nurs Sci. 2018;6:70–91. doi:10.1016/j.ijnss.2018.12.002
  • Ojo O, Wang XH, Ojo OO, et al. The Effects of COVID-19 lockdown on glycaemic control and lipid profile in patients with type 2 diabetes: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19:1095. doi:10.3390/ijerph19031095
  • Han Y, Chen Y, Sun C, Zhou Z. The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: a systematic review and meta-analysis of 22 observational studies. Front Endocrinol. 2022;13:1069559. doi:10.3389/fendo.2022.1069559
  • Wafa IA, Pratama NR, Sofia NF, et al. Impact of COVID-19 lockdown on the metabolic control parameters in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J. 2022;46:260–272. doi:10.4093/dmj.2021.0125
  • O’Mahoney LL, Highton PJ, Kudlek L, et al. The impact of the COVID-19 pandemic on glycaemic control in people with diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2022;24:1850–1860. doi:10.1111/dom.14771
  • D’Onofrio L, Pieralice S, Maddaloni E, et al. Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study. Diabetes Obes Metab. 2021;23:1624–1630. doi:10.1111/dom.14380
  • World Health Organization. Global Recommendations on Physical Activity for Health. Geneva: World Health Organization; 2010.
  • ElSayed NA, Aleppo G, Aroda VR, et al.; on behalf of the American Diabetes Association. Glycemic targets: standards of care in diabetes-2023. Diabetes Care. 46;2023:S97–110. doi:10.2337/dc23-S006
  • Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254. doi:10.7326/0003-4819-145-4-200608150-00004
  • Lashkarbolouk N, Mazandarani M, Pourghazi F, et al. How did lockdown and social distancing policies change the eating habits of diabetic patients during the COVID-19 pandemic? A systematic review. Front Psychol. 2022;13:1002665. doi:10.3389/fpsyg.2022.1002665
  • Lin CL, Huang LC, Chang YT, Chen RY, Yang SH. Under COVID-19 pandemic: a quasi-experimental trial of observation on diabetes patients’ health behavior affected by the pandemic from a coaching intervention program. Front Public Health. 2021;9:580032. doi:10.3389/fpubh.2021.580032
  • Park SD, Kim SW, Moon JS, et al. Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus. Diabetes Metab J. 2021;45:109–114. doi:10.4093/dmj.2020.0226
  • Biamonte E, Pegoraro F, Carrone F, et al. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Endocrine. 2021;72:604–610. doi:10.1007/s12020-021-02739-5
  • Munekawa C, Hosomi Y, Hashimoto Y, et al. Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study. Endocr J. 2021;68:201–210. doi:10.1507/endocrj.EJ20-0426
  • Ludwig L, Scheyer N, Remen T, Guerci B. The impact of COVID-19 lockdown on metabolic control and access to healthcare in people with diabetes: the CONFI-DIAB cross-sectional study. Diabetes Ther. 2021;12:2207–2221. doi:10.1007/s13300-021-01105-y
  • Alyahya MS, Okour NS, Khader Y, Al-Sheyab N. Retrospective study on the impact of COVID-19 lockdown on patients with type 2 diabetes in Northern Jordan. BMJ Open. 2022;12:e065148. doi:10.1136/bmjopen-2022-065148
  • Mohseni M, Ahmadi S, Azami-Aghdash S, et al. Challenges of routine diabetes care during COVID-19 era: a systematic search and narrative review. Prim Care Diabetes. 2021;15:918–922. doi:10.1016/j.pcd.2021.07.017
  • Amsah N, Md Isa Z, Ahmad N, Abdul Manaf MR. Impact of COVID-19 pandemic on healthcare utilization among patients with type 2 diabetes mellitus: a systematic review. Int J Environ Res Public Health. 2023;20:4577. doi:10.3390/ijerph20054577
  • Cheng YC, Li YH, Liu HC, et al. The Impact of a Lockdown for the COVID-19 Pandemic on Seasonal HbA1c Variation in Patients with Type 2 Diabetes. Life. 2023;13:763. doi:10.3390/life13030763
  • Ilias I, Rizzo M, Zabuliene L. Metformin: sex/gender differences in its uses and effects-narrative review. Medicina. 2022;58:430. doi:10.3390/medicina58030430
  • Arnetz L, Ekberg NR, Alvarsson M. Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes. 2014;7:409–420. doi:10.2147/DMSO.S51301
  • Schütt M, Zimmermann A, Hood R, et al. DPV initiative; German BMBF competence network diabetes mellitus. gender-specific effects of treatment with lifestyle, metformin or sulfonylurea on glycemic control and body weight: a German multicenter analysis on 9 108 patients. Exp Clin Endocrinol Diabetes. 2015;123:622–626. doi:10.1055/s-0035-1559608